Leaders of TodayLeaders of Today
BrowseWorkspaceProfile
Leaders of Today

Every opportunity worth finding, checked against its source.

Submit an Opportunity
Leaders of TodayAbout UsBlogContactReport a Bug
LegalCookiesDisclaimerPrivacy PolicyTerms of Service

© 2026 Leaders of Today™. All Rights Reserved.

This opportunity has closed. It stays published for reference, and new cycles reopen here when the organizer announces them. Browse open opportunities

Merck Digital Sciences Studio (MDSS) – 2026 Accelerator Program

  • Organization: Merck , Centech, The Venture Collective, CQDM
  • Type: Other
  • Location: North America - Canada, United States
  • Deadline: November 28, 2025
  • Age: No age requirement mentioned
  • Funding: Fully Funded

The MDSS is a nine‑month accelerator designed to help startups scale digital solutions for drug discovery and development. Key features: - SAFE investment from Merck Global Health Innovation Fund (GHI) - Mentorship from Merck experts and Centech advisors - Azure Cloud computing credits to accelerate R&D - Access to Merck scientists for piloting technologies in discovery and clinical settings - Networking with investors, pharma leaders, and innovation hubs in the US and Canada - Focus areas: AI/ML for drug discovery, digital biomarkers, clinical trial optimization, translational medicine platforms

Apply for Merck Digital Sciences Studio (MDSS) – 2026 Accelerator Program

Merck , Centech, The Venture Collective, CQDMOther

Merck Digital Sciences Studio (MDSS) – 2026 Accelerator Program

This one has closed
Archived
Opportunity type
Other
Funding
Fully Funded
Location
Global
Deadline
Archived

About this opportunity

The MDSS is a nine‑month accelerator designed to help startups scale digital solutions for drug discovery and development. Key features:

  • SAFE investment from Merck Global Health Innovation Fund (GHI)
  • Mentorship from Merck experts and Centech advisors
  • Azure Cloud computing credits to accelerate R&D
  • Access to Merck scientists for piloting technologies in discovery and clinical settings
  • Networking with investors, pharma leaders, and innovation hubs in the US and Canada
  • Focus areas: AI/ML for drug discovery, digital biomarkers, clinical trial optimization, translational medicine platforms

Who can apply

  • Early‑stage startups (Seed – Series A)
  • Focus on digital health or biotech innovation aligned with Merck’s therapeutic areas
  • Must demonstrate:
  • Validated MVP or prototype
  • Potential for scalability and clinical impact
  • Must submit:
  • Online application form
  • Pitch deck and business plan
  • Evidence of team capacity

LOT finds and checks opportunities from public sources. Always confirm details on the organiser’s own page before applying.

Merck Digital Sciences Studio (MDSS) – 2026 Accelerator Program
Archived
This one has closed